$19.42
Phibro Animal Health Corporation is a drug manufacturers - specialty & generic business based in the US. Phibro Animal Health Corporation shares (PAHC) are listed on the NASDAQ and all prices are listed in US Dollars. Phibro Animal Health Corporation employs 1,940 staff and has a trailing 12-month revenue of around $1 billion.
What's in this guide?
Our top picks for where to buy Phibro Animal Health Corporation stock
How to buy Phibro Animal Health Corporation stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PAHC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Phibro Animal Health Corporation stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Phibro Animal Health Corporation stock price (NASDAQ: PAHC)
Use our graph to track the performance of PAHC stocks over time.Phibro Animal Health Corporation shares at a glance
Latest market close | $19.65 |
---|---|
52-week range | $9.15 - $22.31 |
50-day moving average | $18.26 |
200-day moving average | $14.51 |
Wall St. target price | $14.00 |
PE ratio | 350 |
Dividend yield | $0.48 (2.28%) |
Earnings per share (TTM) | $0.06 |
Is it a good time to buy Phibro Animal Health Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Phibro Animal Health Corporation price performance over time
Historical closes compared with the close of $19.65 from 2024-09-04
1 week (2024-08-29) | -8.48% |
---|---|
1 month (2024-08-05) | 13.72% |
3 months (2024-06-05) | 13.58% |
6 months (2024-03-05) | 48.53% |
1 year (2023-09-05) | 46.31% |
---|---|
2 years (2022-09-02) | 34.04% |
3 years (2021-09-03) | 23.72 |
5 years (2019-09-05) | 20.423 |
Is Phibro Animal Health Corporation stock undervalued or overvalued?
Valuing Phibro Animal Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Phibro Animal Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Phibro Animal Health Corporation's P/E ratio
Phibro Animal Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 350x. In other words, Phibro Animal Health Corporation shares trade at around 350x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Phibro Animal Health Corporation's PEG ratio
Phibro Animal Health Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6618. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Phibro Animal Health Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Phibro Animal Health Corporation's EBITDA
Phibro Animal Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $94.1 million.
The EBITDA is a measure of a Phibro Animal Health Corporation's overall financial performance and is widely used to measure a its profitability.
Phibro Animal Health Corporation financials
Revenue TTM | $1 billion |
---|---|
Operating margin TTM | 8.57% |
Gross profit TTM | $298.2 million |
Return on assets TTM | 3.8% |
Return on equity TTM | 0.9% |
Profit margin | 0.24% |
Book value | $6.34 |
Market Capitalization | $850.6 million |
TTM: trailing 12 months
Phibro Animal Health Corporation share dividends
Dividend payout ratio: 40.34% of net profits
Recently Phibro Animal Health Corporation has paid out, on average, around 40.34% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.28% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Phibro Animal Health Corporation shareholders could enjoy a 2.28% return on their shares, in the form of dividend payments. In Phibro Animal Health Corporation's case, that would currently equate to about $0.48 per share.
While Phibro Animal Health Corporation's payout ratio might seem fairly standard, it's worth remembering that Phibro Animal Health Corporation may be investing much of the rest of its net profits in future growth.
Phibro Animal Health Corporation's most recent dividend payout was on 24 September 2024. The latest dividend was paid out to all shareholders who bought their shares by 3 September 2024 (the "ex-dividend date").
Phibro Animal Health Corporation share price volatility
Over the last 12 months, Phibro Animal Health Corporation's shares have ranged in value from as little as $9.1456 up to $22.305. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Phibro Animal Health Corporation's is 0.517. This would suggest that Phibro Animal Health Corporation's shares are less volatile than average (for this exchange).
Phibro Animal Health Corporation overview
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries.
Frequently asked questions
What percentage of Phibro Animal Health Corporation is owned by insiders or institutions?Currently 0.543% of Phibro Animal Health Corporation shares are held by insiders and 102.687% by institutions. How many people work for Phibro Animal Health Corporation?
Latest data suggests 1,940 work at Phibro Animal Health Corporation. When does the fiscal year end for Phibro Animal Health Corporation?
Phibro Animal Health Corporation's fiscal year ends in June. Where is Phibro Animal Health Corporation based?
Phibro Animal Health Corporation's address is: Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712 What is Phibro Animal Health Corporation's ISIN number?
Phibro Animal Health Corporation's international securities identification number is: US71742Q1067 What is Phibro Animal Health Corporation's CUSIP number?
Phibro Animal Health Corporation's Committee on Uniform Securities Identification Procedures number is: 71742Q106
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question